RCMNY
Rubric Capital Management (New York) Portfolio holdings
AUM
$6.22B
This Quarter Return
+14.68%
1 Year Return
+46.93%
3 Year Return
+140.96%
5 Year Return
+327.45%
10 Year Return
–
AUM
$3.38B
AUM Growth
+$3.38B
(+26%)
Cap. Flow
+$485M
Cap. Flow
% of AUM
14.35%
Top 10 Holdings %
Top 10 Hldgs %
44.12%
Holding
72
New
14
Increased
22
Reduced
16
Closed
3
Top Buys
| 1 |
Vistra
VST
|
$84.6M |
| 2 |
iShares Bitcoin Trust
IBIT
|
$69.7M |
| 3 |
QuidelOrtho
QDEL
|
$68.1M |
| 4 |
Fluor
FLR
|
$46.1M |
| 5 |
Extreme Networks
EXTR
|
$39.8M |
Top Sells
| 1 |
Collegium Pharmaceutical
COLL
|
$35.9M |
| 2 |
GoodRx Holdings
GDRX
|
$26.7M |
| 3 |
Koppers
KOP
|
$24M |
| 4 |
Mr. Cooper
COOP
|
$20.8M |
| 5 |
SILK
Silk Road Medical, Inc. Common Stock
SILK
|
$17.5M |
Sector Composition
| 1 | Healthcare | 47.6% |
| 2 | Technology | 8.46% |
| 3 | Financials | 7.86% |
| 4 | Industrials | 6.07% |
| 5 | Materials | 5.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
OmniAb
OABI
$219M
| $15.5M | 0.46% |
2,850,588
| – | – |
|
|
52
GoodRx Holdings
GDRX
$1.49B
| $15M | 0.44% |
2,117,054
-3,755,752
| -64% | -$26.7M |
|
53
Ardelyx
ARDX
$1.57B
| $13.3M | 0.39% |
1,816,585
-2,196,168
| -55% | -$16M |
|
|
RVNC
54
DELISTED
Revance Therapeutics, Inc.
RVNC
| $13.1M | 0.39% |
2,656,847
+1,195,373
| +82% | +$5.88M |
|
55
Cullinan Oncology
CGEM
$456M
| $10.7M | 0.32% |
626,929
| – | – |
|
56
Werewolf Therapeutics
HOWL
$62.6M
| $10.5M | 0.31% |
1,621,034
-314,323
| -16% | -$2.04M |
|
57
Pediatrix Medical
MD
$1.45B
| $9.11M | 0.27% |
+908,600
| New | +$9.11M |
|
58
Telesat
TSAT
$307M
| $8.18M | 0.24% |
959,764
| – | – |
|
59
PLAYSTUDIOS Inc
MYPS
$118M
| $6.59M | 0.19% |
2,368,777
+407,593
| +21% | +$1.13M |
|
60
ARS Pharmaceuticals
SPRY
$1.08B
| $6.53M | 0.19% |
639,203
| – | – |
|
61
Opko Health
OPK
$1.1B
| $5.92M | 0.18% |
+4,935,814
| New | +$5.92M |
|
62
Protagonist Therapeutics
PTGX
$3.62B
| $5.73M | 0.17% |
+198,059
| New | +$5.73M |
|
63
Carpenter Technology
CRS
$11.8B
| $5.62M | 0.17% |
+78,661
| New | +$5.62M |
|
|
BCYC
64
Bicycle Therapeutics
BCYC
$492M
| $5.12M | 0.15% |
205,423
| – | – |
|
65
TherapeuticsMD
TXMD
$12.7M
| $2.73M | 0.08% |
1,192,191
| – | – |
|
66
Xeris Biopharma Holdings
XERS
$1.27B
| $687K | 0.02% |
+310,959
| New | +$687K |
|
|
VINC
67
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
| $591K | 0.02% |
116,873
-237,504
| -67% | -$1.2M |
|
|
SILK
68
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| – | – |
-1,427,905
| Closed | -$17.5M |
|
69
Sutro Biopharma
STRO
$85.6M
| – | – |
-3,344,810
| Closed | -$14.3M |
|
70
SPDR S&P 500 ETF Trust
SPY
$656B
| – | – |
0
| – | – |
|
71
Pacira BioSciences
PCRX
$1.22B
| – | – |
-491,322
| Closed | -$16.6M |
|